Influence of origin of ovarian cancer on efficacy of screening

被引：28

作者：

Scully, RE ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Homer Wright Pathol Labs, Boston, MA 02114 USA

来源：

LANCET | 2000年 / 355卷 / 9209期

关键词：

D O I：

10.1016/S0140-6736(00)02026-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1028 / 1029

页数：2

共 12 条

[1]

BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO

[2]

2-L

[3]

BELL DA, IN PRESS PATHOLOGY I

[4] CHARACTERISTICS OF PERSISTENT OVARIAN MASSES IN ASYMPTOMATIC WOMEN [J].

BHAN, V ;

AMSO, N ;

WHITEHEAD, MI ;

CAMPBELL, S ;

ROYSTON, P ;

COLLINS, WP .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (12) :1384-1391

[5] Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors [J].

Caduff, RF ;

Svoboda-Newman, SM ;

Ferguson, AW ;

Johnston, CN ;

Frank, TS .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (03) :323-328

[6] Ovarian dysplasia: A review [J].

Deligdisch, L .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (02) :89-94

[7]

PECORELLI S, 1998, J EPIDEMIOL BIOSTAT, V3, P1

[8] TRANSITION FROM BENIGN TO MALIGNANT EPITHELIUM IN MUCINOUS AND SEROUS OVARIAN CYSTADENOCARCINOMA [J].

PULS, LE ;

POWELL, DE ;

DEPRIEST, PD ;

GALLION, HH ;

HUNTER, JE ;

KRYSCIO, RJ ;

VANNAGELL, JR .

GYNECOLOGIC ONCOLOGY, 1992, 47 (01) :53-57

[9]

Rosenthal A, 1998, SEMIN ONCOL, V25, P315

[10]

Russell P., 1997, SURG PATHOLOGY OVARI, V2nd sub ed

← 1 2 →